Skip to main content

Does the type of wine matter?

Questions that seem to come up frequently when I am lecturing about wines include “Does it have to be red in order to get the health benefits?” and “Which types of wine have the highest amount of the healthful polyphenols?” To answer the first, red wines do have much higher levels of resveratrol and other beneficial compounds for several reasons. Since these compounds come from the skins and seeds, the whole grape (berry) must be fermented together in order for optimal extraction. White wines are made by pressing out the juice and then fermenting it without contact of the skins and seeds. So yes, it has to be red for the full dose, and it has to be wine not grape juice.


The second question is a bit trickier. There are natural variations among the different varietals of grapes that wine is made from, but the terroir (local conditions) and methods of viticulture probably have more to do with it. To understand why this is the case, consider why grapes make resveratrol and other polyphenols in the skins in the first place: it is for protection against environmental stress. That is of course the reason why they are such potent antioxidants and anti-microbial agents.

One grape that seems to struggle mightily is pinot noir, so pinots are known to have high levels. One Oregon producer of pinot noir wines has petitioned for permission to state resveratrol content in the wines, which the government has resisted because people might start thinking that wine is actually a healthy beverage (it is.) But other reds have healthy polyphenol content too, and there are several studies now comparing the amount of resveratrol in similar wines from different parts of the world and with different traditions of winemaking.

In the end it may not be all that important, since the evidence that resveratrol explains all of the benefits of wine is pretty scant; for one thing, even wines with high resveratrol levels still don’t have much compared to the amounts used in laboratory studies. Other studies point to the combination of all of the compounds in wine working together as the key, including alcohol. So the answer is drink whatever kind of red wine you enjoy, and if you don’t like red maybe you should continue looking for one that you can at least suffer through.

Comments

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

new resveratrol revelations

What a year it has been for resveratrol, the polyphenol molecule from red wine. Last year at this time it was the toast of the town, having been credited with triggering a metabolic change leading to increased lifespan in experimental models, then catapulted into the limelight as a potential cancer cure with clinical trials under the auspices of pharma giant GlaxoSmithKline. Sales of resveratrol supplements were skyrocketing, with audacious claims about weight loss, brain power, and longevity, never mind that none of this had been proven in humans. But with the new year came new controversy. Two of Glaxo’s competitors, Pfizer and Amgen, published their own studies on resveratrol, concluding that the longevity effect was false, an artifact of the testing method. What few clinical trials there are in humans revealed that it is poorly absorbed and doesn’t last very long in the body anyway. Then in November Glaxo abruptly announced the suspension of the clinical trial and all further devel...